Periodic Reporting for period 1 - CINK (Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers)

Cancer immunotherapy has become a powerful weapon for the treatment of cancer in the last decades. Yet the design of an effective immunotherapy is complicated by various factors such as tumor-specific scape mechanisms that renders an immunosuppressive environment...